Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1981-02-02
1986-04-22
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
045843058
ABSTRACT:
Process of aiding regression and palliation of neoplastic disease in animal and human hosts comprising systemic administration to phenylimidazo[2,1-b]thiazole or a nontoxic acid addition salt thereof. Preferably the active ingredient is administered in a sufficient amount to provide dosages over the range from about 1 mg to about 5 mg/kg of body weight of the host.
REFERENCES:
Renoux et al., Nature, vol. 240, pp. 217-218 12-13-72.
Brugmans Josephus
Janssen Paul A. J.
Pollack William
Tripodi Daniel
Dellenbaugh Geoffrey G.
Goldberg Jerome D.
Janssen Pharmaceutica N.V.
LandOfFree
Aiding the regression of neoplastic disease with 2,3,5,6-tetrahy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aiding the regression of neoplastic disease with 2,3,5,6-tetrahy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aiding the regression of neoplastic disease with 2,3,5,6-tetrahy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1915642